Last reviewed · How we verify
Radio-labeled rodatristat ethyl 600 mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Radio-labeled rodatristat ethyl 600 mg (Radio-labeled rodatristat ethyl 600 mg) — Altavant Sciences GmbH.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Radio-labeled rodatristat ethyl 600 mg TARGET | Radio-labeled rodatristat ethyl 600 mg | Altavant Sciences GmbH | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Radio-labeled rodatristat ethyl 600 mg CI watch — RSS
- Radio-labeled rodatristat ethyl 600 mg CI watch — Atom
- Radio-labeled rodatristat ethyl 600 mg CI watch — JSON
- Radio-labeled rodatristat ethyl 600 mg alone — RSS
Cite this brief
Drug Landscape (2026). Radio-labeled rodatristat ethyl 600 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/radio-labeled-rodatristat-ethyl-600-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab